IEQ Capital’s Tonix Pharmaceuticals TNXP Stock Holding History

IEQ Capital’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.18M	Buy	92,373 +78,015	+543%	+$1.01M	0.01%	1039
2026 Q1	$197K	Buy	+14,358	New	+$221K	﹤0.01%	1706

Other funds holding TNXP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JHC

Jones Hill Capital New York $470M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ishara Investments Los Angeles, California $136M AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

IEQ Capital's TNXP Position: Q2 2026 in Review

IEQ Capital increased its Tonix Pharmaceuticals (TNXP) stake by 543% in Q2 2026, buying an estimated $1.01M and bringing the position to 92,373 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #1039.

IEQ Capital first reported a position in TNXP in Q1 2026 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

IEQ Capital held 92,373 shares of Tonix Pharmaceuticals worth $1.18M as of Q2 2026.
IEQ Capital bought 78,015 Tonix Pharmaceuticals shares in Q2 2026, an estimated $1.01M.
Tonix Pharmaceuticals made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #1039 holding.
IEQ Capital first reported a position in Tonix Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.